Department of Medicine V, Hematology, Oncology and Rheumatology, University of Heidelberg, Heidelberg, Germany.
Department of Hematology and Oncology, University of Halle, Halle, Germany.
Blood. 2020 Jun 4;135(23):2059-2070. doi: 10.1182/blood.2019004121.
Noncoding RNAs, including small nucleolar RNAs (snoRNAs), play important roles in leukemogenesis, but the relevant mechanisms remain incompletely understood. We performed snoRNA-focused CRISPR-Cas9 knockout library screenings that targeted the entire snoRNAnome and corresponding host genes. The C/D box containing SNORD42A was identified as an essential modulator for acute myeloid leukemia (AML) cell survival and proliferation in multiple human leukemia cell lines. In line, SNORD42A was consistently expressed at higher levels in primary AML patient samples than in CD34+ progenitors, monocytes, and granulocytes. Functionally, knockout of SNORD42A reduced colony formation capability and inhibited proliferation. The SNORD42A acts as a C/D box snoRNA and directs 2'-O-methylation at uridine 116 of 18S ribosomal RNA (rRNA). Deletion of SNORD42A decreased 18S-U116 2'-O-methylation, which was associated with a specific decrease in the translation of ribosomal proteins. In line, the cell size of SNORD42A deletion carrying leukemia cells was decreased. Taken together, these findings establish that high-level expression of SNORD42A with concomitant U116 18S rRNA 2'-O-methylation is essential for leukemia cell growth and survival.
非编码 RNA,包括小核仁 RNA(snoRNA),在白血病发生中发挥重要作用,但相关机制仍不完全清楚。我们进行了 snoRNA 为重点的 CRISPR-Cas9 敲除文库筛选,靶向整个 snoRNAnome 和相应的宿主基因。含有 C/D 框的 SNORD42A 被鉴定为急性髓系白血病(AML)细胞存活和增殖的必需调节剂,在多种人类白血病细胞系中均如此。一致地,SNORD42A 在原发性 AML 患者样本中的表达水平始终高于 CD34+祖细胞、单核细胞和粒细胞。功能上,SNORD42A 的敲除降低了集落形成能力并抑制了增殖。SNORD42A 作为 C/D 框 snoRNA,指导 18S 核糖体 RNA(rRNA)上尿嘧啶 116 的 2'-O-甲基化。SNORD42A 的缺失减少了 18S-U116 的 2'-O-甲基化,这与核糖体蛋白翻译的特异性下降有关。同样,携带 SNORD42A 缺失的白血病细胞的细胞大小减小。总之,这些发现表明高水平表达 SNORD42A 并伴有 U116 18S rRNA 2'-O-甲基化对于白血病细胞的生长和存活是必需的。